Related Experiment Videos

Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis

F Violi1, D Ferro, S Basili

  • 1Istituto di I Clinica Medica, University of Rome, Italy.

Insights

Patients with liver failure and high fibrinogen degradation products face a greater risk of gastrointestinal bleeding. This study highlights hyperfibrinolysis as a key indicator of bleeding risk in advanced liver disease.

Area of Science:

  • Hepatology
  • Hematology
  • Coagulation Science

Background:

  • Liver failure significantly impacts coagulation and fibrinolysis.
  • Child-Pugh class C liver failure patients exhibit more severe coagulopathy than class B.
  • Hyperfibrinolysis, indicated by elevated fibrinogen degradation products (FDPs), is a concern in liver disease.

Purpose of the Study:

  • To investigate the relationship between fibrinolysis markers and gastrointestinal bleeding risk in patients with liver failure.
  • To compare coagulation and fibrinolysis profiles between Child-Pugh class B and C liver failure patients.
  • To assess the prognostic value of FDPs and hyperfibrinolytic state in predicting mortality and bleeding events.

Main Methods:

  • Prospective study of 61 patients with Child-Pugh class B (n=23) and C (n=38) liver failure over 3 years.
  • Analysis of coagulation indices including prothrombin activity, activated partial thromboplastin time, bilirubin, fibrinogen, and FDPs.
  • Measurement of circulating plasminogen activator antigen and activity, and plasminogen activator inhibitor antigen and activity in patients with elevated FDPs.

Main Results:

  • Child-Pugh class C patients showed significantly worse coagulation profiles and higher FDPs than class B.
  • 28 patients with FDPs > 10 µg/ml confirmed a hyperfibrinolytic state with increased plasminogen activator and decreased inhibitor.
  • Patients with positive FDPs had higher bilirubin and lower fibrinogen levels.
  • Elevated FDPs (OR=8) and Child-Pugh C (OR=3.5) were associated with a higher risk of gastrointestinal bleeding.
  • 41 patients died during follow-up, 22 from gastrointestinal hemorrhage and 19 from liver failure.

Conclusions:

  • Hyperfibrinolysis, evidenced by elevated FDPs, is prevalent in advanced liver failure and significantly increases the risk of gastrointestinal bleeding.
  • Fibrinogen degradation products serve as a crucial biomarker for assessing bleeding risk and prognosis in liver failure patients.
  • Child-Pugh classification and fibrinolytic markers are essential for risk stratification and management of patients with liver failure.

Related Concept Videos